Optimización de la estrategia de unión en el diseño de compuestos multidiana prometedores para el tratamiento de la enfermedad de Alzheimer

Nozal, Vanesa; García-Rubia, Alfonso; Pérez, Concepción; Martínez, Ana; Palomo, Valle.
An Real Acad Farm ; 85(3): 260-273, jul.-sept. 2019. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-184875

Documentos relacionados

  1. Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence.
  2. Identifying eleven new ferroptosis inhibitors as neuroprotective agents from FDA-approved drugs.
  3. Neuroprotection: Rescue from Neuronal Death in the Brain 2.0.
  4. Total Synthesis of Neuroprotective Agents, (+)-Lycibarbarine A and (-)-Lycibarbarine B.
  5. The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain.
  6. Molecular Mechanisms of Neuroprotection after the Intermittent Exposures of Hypercapnic Hypoxia.
  7. Neuroprotective Potential of Punicalagin, a Natural Component of Pomegranate Polyphenols: A Review.
  8. Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury.
  9. Integrative Proteome Analysis Revels 3-Hydroxybutyrate Exerts Neuroprotective Effect by Influencing Chromatin Bivalency.
  10. 18ß-glycyrrhetinic acid protects neuronal cells from ferroptosis through inhibiting labile iron accumulation and preventing coenzyme Q10 reduction.